OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PTSM: Pharmaceutical Technology Sourcing and Management
December 06, 2017
Formulation and excipient advances address taste masking concerns to improve medication adherence in pediatric, geriatric, and other special patient populations.
In the Lab
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
Understanding the relative strengths and weaknesses of different endotoxin test methods is crucial to maintaining quality and patient safety.
December 01, 2017
Contract Services Update
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
November 27, 2017
Supply Chain Update
Manufacturers and trading partners struggle to meet drug tracking requirements
The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialized products to the United States.
November 22, 2017
Understanding what affects a measurement and implementing appropriate procedures will aid weighing accuracy.
November 20, 2017
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
November 17, 2017
MasterControl has added three new cloud-based analytical solutions to its MasterControl Version 11.7 software for clinical managers and regulatory/submissions professionals.
November 13, 2017
The company has completed a small-scale capacity expansion at its site in Charles City, IA.
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
November 10, 2017
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
November 09, 2017
The company has officially opened a local brand office in South Korean to support its existing business in the region.
November 07, 2017
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
November 02, 2017
Acquisition activity has created some CDMOs with facilities and capabilities that rivals global bio/pharma companies.